SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015726
Filing Date
2020-11-05
Accepted
2020-11-05 16:00:37
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20200930.htm   iXBRL 10-Q 1436323
2 EX-31.1 crdf-093020exhibit311.htm EX-31.1 10812
3 EX-31.2 crdf-093020exhibit312.htm EX-31.2 10783
4 EX-32.1 crdf-093020exhibit321.htm EX-32.1 6220
5 EX-32.2 crdf-093020exhibit322.htm EX-32.2 6179
  Complete submission text file 0001628280-20-015726.txt   6551686

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20200930.xsd EX-101.SCH 43534
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20200930_cal.xml EX-101.CAL 76712
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20200930_def.xml EX-101.DEF 279201
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20200930_lab.xml EX-101.LAB 559835
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20200930_pre.xml EX-101.PRE 380589
11 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20200930_htm.xml XML 1102298
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 201290287
SIC: 2836 Biological Products, (No Diagnostic Substances)